Can IBD patients safely stretch their infusion schedule? new study tests two strategies
NCT ID NCT03841942
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are in deep remission. It compares two methods for gradually increasing the time between infliximab infusions: one based on symptoms and one based on drug levels in the blood. The goal is to see which approach better maintains remission and reduces the number of infusions needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
infliximab
What this could lead to
If successful, this could allow some IBD patients to receive fewer infusions while maintaining remission, reducing treatment burden.
What could go wrong
This is a small, early-stage study. Spacing infusions may increase the risk of disease flare-ups or loss of remission.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP Beaujon Hospital
Paris, France
-
APHP Paris Cochin
Paris, France
-
Amiens University Hospital
Amiens, France
-
Besançon University Hospital
Besançon, France
-
Bordeaux University Hospital
Bordeaux, France
-
CHRU Nancy - Hôpitaux de Brabois
Nancy, France
-
Caen University Hospital
Caen, France
-
Clermont-Ferrand University Hospital
Clermont-Ferrand, France
-
Lille University Hospital
Lille, France
-
Nantes University Hospital
Nantes, France
-
Nice University Hospital
Nice, France
-
Nîmes University Hospital
Nîmes, France
-
Pineton de Chambrun
Montpellier, 34000, France
-
Rennes University Hospital
Rennes, France
-
Saint Etienne University Hospital
Saint-Etienne, France
-
Toulouse University Hospital
Toulouse, France